You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Pramod N Kamalapathy1, Marcos R Gonzalez1, Tom M de Groot1
1Department of Orthopaedic Surgery, Division of Orthopaedic Oncology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Researchers developed machine learning models to predict 5-year survival in patients with leiomyosarcoma (LMS), a rare cancer. The Elastic-Net Penalized Logistic Regression model showed strong performance in external validation, offering a promising tool for survival assessment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: